EUVIMEDEUVIMED entdecken
Crossref

Targeting the NR4A3-RNF139-ATF6 pathway as a therapeutic and diagnostic strategy in bladder cancer

Haiyang Cui, Xuejiao Fan

Pathology - Research and Practice · 2026

DOI: 10.1016/j.prp.2025.156301 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathology - Research and Practice, 2026. Verfasst von Haiyang Cui und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Activating Transcription Factor 6, Receptors, Thyroid Hormone, Receptors, Steroid. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 66 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Bladder cancer (BCa) is a prevalent malignancy with high recurrence and metastasis rates. Nuclear receptor subfamily 4 group A member 3 (NR4A3), a member of the orphan nuclear receptor superfamily, is implicated in various cancers, but its functional role and mechanisms in BCa have not been well understood. This study aimed to explore the functional significance and diagnostic value of NR4A3 in BCa, with a focus on its regulation of endoplasmic reticulum (ER) stress and anoikis sensitivity via ATF6 and RNF139. METHODS: NR4A3 expression in BCa cell lines was assessed by qRT-PCR and Western blot. Gain-of-function assays were performed to evaluate cell proliferation, apoptosis, and anoikis sensitivity in vitro. ER stress markers and ATF6 degradation were examined by immunoblotting, cycloheximide chase, and ubiquitination assays. The role of RNF139 and its regulation by NR4A3 via KLF2 and KLF4 were determined via various biological assays. In vivo tumorigenesis was assessed using a xenograft mouse model. Additionally, the diagnostic performance of NR4A3 was evaluated in 100 clinical patients using serum ELISA and color Doppler ultrasound. RESULTS: NR4A3 was downregulated in BCa cells, and its overexpression suppressed cell proliferation, colony formation and promoted apoptosis and anoikis sensitivity. Mechanistically, NR4A3 inhibited ER stress by promoting ATF6 ubiquitination and degradation via transcriptional activation of RNF139 through KLF2 and KLF4. RNF139 directly interacted with ATF6 and mediated its ubiquitination at lysine 152. In vivo, NR4A3 overexpression inhibited tumor growth. Clinically, combining color Doppler ultrasound with serum NR4A3 levels significantly improved diagnostic accuracy for BCa (AUC = 0.986). CONCLUSION: NR4A3 suppresses BCa progression via the KLF2/4-RNF139-ATF6 axis and enhances diagnostic efficacy when combined with ultrasound imaging.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsActivating Transcription Factor 6Receptors, Thyroid HormoneReceptors, SteroidDNA-Binding ProteinsUbiquitin-Protein LigasesHumansAnimalsFemaleMiceMaleKruppel-Like Factor 4Cell Line, TumorSignal TransductionMiddle AgedCell ProliferationEndoplasmic Reticulum StressGene Expression Regulation, NeoplasticAgedBiomarkers, TumorApoptosis

Stichwörter der Autor:innen

ATF6Bladder cancerDiagnostic biomarkerER stressNR4A3

Substanzen

Activating Transcription Factor 6NR4A3 protein, humanReceptors, Thyroid HormoneKruppel-Like Factor 4ATF6 protein, humanKLF4 protein, humanKlf4 protein, mouseReceptors, SteroidDNA-Binding ProteinsUbiquitin-Protein Ligases

Autor:innen und Institutionen

  • Department of Radiation Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China.
  • Department of Medical Imaging, Liaoning Cancer Hospital & Institute, No.44 Xiaoheyan Road, Dadong District, Shenyang, Liaoning 110042, China. Electronic address: lucky19891204@163.com.

Zitieren

APA

Cui, H., & Fan, X. (2026). Targeting the NR4A3-RNF139-ATF6 pathway as a therapeutic and diagnostic strategy in bladder cancer. Pathology - Research and Practice. https://doi.org/10.1016/j.prp.2025.156301

Vancouver

Cui H, Fan X. Targeting the NR4A3-RNF139-ATF6 pathway as a therapeutic and diagnostic strategy in bladder cancer. Pathology - Research and Practice. 2026. doi:10.1016/j.prp.2025.156301

BibTeX
@article{Cui2026,
  author = {Cui, Haiyang and Fan, Xuejiao},
  title = {Targeting the NR4A3-RNF139-ATF6 pathway as a therapeutic and diagnostic strategy in bladder cancer},
  journal = {Pathology - Research and Practice},
  year = {2026},
  doi = {10.1016/j.prp.2025.156301}
}
Kostenlos starten →